A prescription model for vapes: the way we 'do' medicines policy in Australia.
Public Health Res Pract
; 34(2)2024 Jun 19.
Article
in En
| MEDLINE
| ID: mdl-38763779
ABSTRACT
On 2 May 2023, the Australian Federal Government announced a suite of reforms aimed at ensuring the effectiveness of the prescription model of regulation of vaping (or e-cigarette) products in Australia. These reforms are intended to protect Australians, particularly young people, from the harms of vaping and nicotine dependence. The ensuing public debate on the issue has often created the impression that the options under consideration are to either retain 'recently introduced' prescription regulation or to 'revert to' a retail supply approach. However, the sale of nicotine vapes by retailers such as tobacconists and convenience stores has never been lawful in Australia. The reforms do not seek to change the way nicotine vaping products are regulated, but rather to ensure that the existing prescription model can be effectively enforced and can function as originally intended. This paper describes the historical context and rationale for strengthening prescription regulation of vapes in this country.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaping
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Public Health Res Pract
Year:
2024
Document type:
Article
Affiliation country:
Australia
Country of publication:
Australia